Abstract
There have been several endeavors made to investigate the potential role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography (FDG-PET) (and tracers) and PET-computed tomography imaging in various benign disorders, particularly those related to thoracic structures. These various conditions can be broadly categorized into three groups: (a) infectious diseases (mycobacterial, fungal, bacterial infection), (b) active granulomatous disease such as sarcoidosis, and (c) other non-infectious/inflammatory conditions or proliferative disorders (e.g., radiation pneumonitis, post-lung transplant lymphoproliferative disorders, occupational pleuropulmonary complications, and post-surgical conditions), all of which can demonstrate varying degrees of FDG uptake on PET scans based upon the degree of inflammatory activity. This article reviews the current state of this very important application of FDG–PET imaging.
Similar content being viewed by others
References
Karam M, Roberts-Klein S, Shet N, Chang J, Feustel P (2008) Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology. J Nucl Med 49(9):1429–1436
Bataille L, Lonneux M, Weynand B, Schoonbroodt D, Collard P, Deprez PH (2008) EUS–FNA and FDG–PET are complementary procedures in the diagnosis of enlarged mediastinal lymph nodes. Acta Gastroenterol Belg 71(2):219–229
Sochocky S (1958) Tuberculoma of the lung. Am Rev Tuberc 78(3):403–410
Palmer PE (1979) Pulmonary tuberculosis—usual and unusual radiographic presentations. Semin Roentgenol 14(3):204–243
Braun JJ, Kessler R, Constantinesco A, Imperiale A (2008) (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 35(8):1537–1543, Epub 2008 Apr 17
Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211
Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA (2007) Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 29(2):418–422
Hyodo E, Hozumi T, Takemoto Y et al (2004) Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 90:1275–1280
Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M (2004) The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 94:99–103
Yamagishi H, Shirai N, Takagi M et al (2003) Identification of cardiac sarcoidosis with 13N–NH3/18F-FDG PET. J Nucl Med 44:1030–1036
Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M (2004) Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45(12):1989–1998
Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26(15):1538–1543, Epub 2005 Apr 4
Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, Zhuang H (2002) Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32(4):293–321
Basu S, Alavi A (2007) Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. Clin Nucl Med 32(5):407–408
Basu S, Alzeair S, Li G, Dadparvar S, Alavi A (2007) Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease. Mol Imaging Biol 9(6):333–339
Shukuya T, Naka G, Kawana A, Sugiyama H, Kobayashi N, Kudo K, Yago Y, Tamegai Y, Kubota K (2006) Pneumoconiosis associated with an esophageal ulcer and uptake revealed in FDGPET. Intern Med 45(5):293–296, Epub 2006 Apr 3
Bandoh S, Fujita J, Yamamoto Y, Nishiyama Y, Ueda Y, Tojo Y, Ishii T, Kubo A, Ishida T (2003) A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography. Ann Nucl Med 17(7):597–600
Williams HT, Solis V, Dillard TA, Gossage JR Jr, Freant LJ (2008) Malignancy in kaolin pneumoconiosis found with F-18 FDG positron emission tomography. Clin Nucl Med 33(1):4–7
Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, Zhao S, Okamoto S, Tamaki N (2007) Comparison of MET–PET and FDG–PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 21(6):331–337, Epub 2007 Aug 27
O’Connell M, Kennedy M (2004) Progressive massive fibrosis secondary to pulmonary silicosis appearance on F-18 fluorodeoxyglucose PET/CT. Clin Nucl Med 29(11):754–755
Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC, Bonnaud F (2004) Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 24(5):814–821
Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST (2002) Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 43(9):1144–1149
Mavi A, Basu S, Cermik TF, Urhan M, Bathaii M, Thiruvenkatasamy D, Houseni M, Dadparvar S, Alavi A (2009) Potential of dual time point FDG–PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol 11(5):369–378
Marom EM, McAdams HP, Butnor KJ, Coleman RE (2004) Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG–PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. J Thorac Imaging 19(2):74–78
Bakheet SM, Powe J (1998) Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28:352–358
Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH (1999) A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr 171:49–53
Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S et al (2003) Pulmonary paragonimiasis mimicking lung cancer on FDG–PET imaging. Anticancer Res 23:3437–3440
Lin P, Chu J, Pocock N (2000) Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med 25:866–869
Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M et al (2001) FDG–PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 19:215–218
Yun M, Yeh D, Araujo LI et al (2001) F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26(4):314–319
Yun M, Jang S, Cucchiara A et al (2002) 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32(1):70–76
Bural GG, Torigian DA, Chamroonrat W, Alkhawaldeh K, Houseni M, El-Haddad G, Alavi A (2006) Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG–PET and CT image analysis: a new concept. Nucl Med Biol 33(8):1037–1043, Epub 2006 Oct 4
Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A (2008) FDG–PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35(3):562–569
Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU (2005) The value of [18F]FDG–PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674–681
Blockmans D, De CL, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137
Hautzel H, Sander O, Heinzel A, Schneider M, Müller HW (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49(7):1107–1113, Epub 2008 Jun 13
Meller J, Strutz F, Siefker J et al (2003) Early diagnosis and follow-up of aortitis with F-18 FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730–736
Webb M, Chambers A, Al-Nahhas A et al (2004) The role of F-18-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31:627–634
Hara M, Goodman PC, Leder RA (1999) FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23:16–18, Full Text via CrossRef
Dumarey N, Tang BN, Goldman S, Wautrecht JC, Matos C, Unger P, Nortier J (2007) Papillary muscle inflammation in Takayasu’s arteritis revealed by FDG–PET. Eur Heart J 28(8):1011
Blockmans D, Maes A, Stroobants S et al (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38:444–447
Moosig F, Czech N, Mehl C et al (2004) Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63:870–873
Wildhagen K, Meyer GJ, Stoppe G, Heintz P, Deicher H, Hundeshagen H (1989) PET and MR imaging in a neuro-Behçet syndrome. Eur J Nucl Med 15(11):764–766
Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K, Nagata K (1989) Sequential PET studies in neuro-Behçet’s syndrome. J Neurol 236(6):367–370
Terada T (1991) Magnetic resonance imaging in neuro-Behçet’s disease—comparison with clinical, X-ray CT, and PET findings. Ryumachi 31(2):175–183
Otte A, Weiner SM, Hoegerle S, Wolf R, Juengling FD, Peter HH, Nitzsche EU (1998) Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 7(1):57–59
Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377–385
Stoppe G, Wildhagen K, Meyer GJ, Schober O (1989) Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI. Nuklearmediziner 28(5):187–192
Meyer GJ, Schober O, Stoppe G, Wildhagen K, Seidel JW, Hundeshagen H (1989) Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods. Psychiatry Res 29(3):367–368
Wildhagen K, Stoppe G, Meyer GJ, Heintz P, Hundeshagen H, Deicher H (1989) Imaging diagnosis of central nervous system involvement in panarteritis nodosa. Z Rheumatol 48(6):323–325
Park IN, Ryu JS, Shim TS (2008) Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 33(1):1–3
Chamilos G, Macapinlac HA, Kontoyiannis DP (2008) The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 46(1):23–29
Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92:2719–2724
Bleeker-Rovers CP, Warris A, Drenth JP, Corstens FH, Oyen WJ, Kullberg BJ (2005) Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 11:493–495
Win Z, Todd J, Al-Nahhas A (2005) FDG–PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 30:690–691
Basu S, Asopa RV, Baghel NS (2009) Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG–PET. Clin Nucl Med 34(10):689–690
Jones HA, Marino PS, Shakur BS, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 21:567–573
Chen DL, Schuster DP (2004) Positron emission tomography with 18F-fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L834–L840
Jones HA, Clark JC, Minhas PS, Kendall IV, Downey SP, Menon DK (1998) Pulmonary neutrophil activation following head trauma. Am J Respir Crit Care Med 157:A349
Conflict of Interest Statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basu, S., Saboury, B., Werner, T. et al. Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders. Mol Imaging Biol 13, 1051–1060 (2011). https://doi.org/10.1007/s11307-010-0459-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-010-0459-x